Stryker Australia Pty Ltd - Tornier Perform Reversed Glenoid Glenosphere - Reverse shoulder prosthesis head 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

stryker australia pty ltd - tornier perform reversed glenoid glenosphere - reverse shoulder prosthesis head

stryker australia pty ltd - 48093 - reverse shoulder prosthesis head - a hemispherical component of the tornier perform reversed glenoid system intended to be attached to the baseplate to articulate with a congruent reverse shoulder insert. the glenosphere is made of cobalt chromium alloy and contains a morse taper connection that mates with a taper on the baseplate components. it also includes assembled subcomponents that make up a captured locking screw used as secondary locking mechanism to lock the glenosphere onto the baseplate in addition to the taper. a component of the tornier perform reversed glenoid system intended for replacement of the glenoid part of the scapulohumeral joint as part of a reverse shoulder prosthesis. the system is intended to reduce pain and improve shoulder mobility, in comparison with preoperative status, in patients with a functional deltoid muscle and with a massive and non-repairable rotator cuff-tear.

ENTRIP amitriptyline hydrochloride 50 mg tablets blister pack 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

entrip amitriptyline hydrochloride 50 mg tablets blister pack

arrotex pharmaceuticals pty ltd - amitriptyline hydrochloride, quantity: 50 mg - tablet - excipient ingredients: lactose monohydrate; microcrystalline cellulose; maize starch; croscarmellose sodium; colloidal anhydrous silica; purified talc; magnesium stearate; macrogol 6000; hypromellose; titanium dioxide; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - for the treatment of major depression. entrip 50mg tablets are indicated only for the maintenance treatment of major depression (see precautions). nocturnal enuresis where organic pathology has been excluded.

ENTRIP amitriptyline hydrochloride 25 mg tablets blister pack 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

entrip amitriptyline hydrochloride 25 mg tablets blister pack

arrotex pharmaceuticals pty ltd - amitriptyline hydrochloride, quantity: 25 mg - tablet - excipient ingredients: lactose monohydrate; microcrystalline cellulose; maize starch; croscarmellose sodium; colloidal anhydrous silica; purified talc; magnesium stearate; macrogol 6000; hypromellose; titanium dioxide; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - for the treatment of major depression. nocturnal enuresis where organic pathology has been excluded.

ENTRIP amitriptyline hydrochloride 10 mg tablets blister pack 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

entrip amitriptyline hydrochloride 10 mg tablets blister pack

arrotex pharmaceuticals pty ltd - amitriptyline hydrochloride, quantity: 10 mg - tablet - excipient ingredients: lactose monohydrate; microcrystalline cellulose; maize starch; croscarmellose sodium; colloidal anhydrous silica; purified talc; magnesium stearate; macrogol 6000; hypromellose; titanium dioxide; brilliant blue fcf aluminium lake; polyvinyl alcohol; macrogol 3350 - for the treatment of major depression. nocturnal enuresis where organic pathology has been excluded.

AZACITIDINE JUNO azacitidine 100 mg powder for injection vial 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

azacitidine juno azacitidine 100 mg powder for injection vial

dr reddys laboratories australia pty ltd - azacitidine, quantity: 100 mg - injection, powder for - excipient ingredients: mannitol - azacitidine juno is indicated for the treatment of patients with intermediate-2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss), chronic myelomonocytic leukemia (cmmol (10-29 percent marrow blasts without myeloproliferative disorder)), acute myeloid leukemia (aml) with 20-30 percent blasts and multi-lineage dysplasia, according to world health organisation classification (who), in whom allogenic stem cell transplantation is not indicated.

AZADINE azacitidine 100 mg powder for injection vial 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

azadine azacitidine 100 mg powder for injection vial

dr reddys laboratories australia pty ltd - azacitidine, quantity: 100 mg - injection, powder for - excipient ingredients: mannitol - azadine is indicated for the treatment of patients with intermediate-2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss), chronic myelomonocytic leukemia (cmmol (10-29 percent marrow blasts without myeloproliferative disorder)), acute myeloid leukemia (aml) with 20-30 percent blasts and multi-lineage dysplasia, according to world health organisation classification (who), in whom allogenic stem cell transplantation is not indicated.

PPA-AMITRIPTYLINE amitriptyline hydrochloride 50mg tablet bottle pack 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

ppa-amitriptyline amitriptyline hydrochloride 50mg tablet bottle pack

ipca pharma (australia) pty ltd - amitriptyline hydrochloride, quantity: 50 mg - tablet - excipient ingredients: crospovidone; maize starch; lactose monohydrate; microcrystalline cellulose; purified talc; macrogol 6000; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; sunset yellow fcf aluminium lake; indigo carmine aluminium lake - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

PIP-AMITRIPTYLINE amitriptyline hydrochloride 25mg tablet blister pack 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

pip-amitriptyline amitriptyline hydrochloride 25mg tablet blister pack

ipca pharma (australia) pty ltd - amitriptyline hydrochloride, quantity: 25 mg - tablet - excipient ingredients: magnesium stearate; lactose monohydrate; crospovidone; titanium dioxide; purified talc; maize starch; microcrystalline cellulose; quinoline yellow aluminium lake; hypromellose; macrogol 6000; colloidal anhydrous silica - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

AMIDEP amitriptyline hydrochloride 10mg tablet blister pack 오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

amidep amitriptyline hydrochloride 10mg tablet blister pack

ipca pharma (australia) pty ltd - amitriptyline hydrochloride, quantity: 10 mg - tablet - excipient ingredients: magnesium stearate; titanium dioxide; crospovidone; lactose monohydrate; microcrystalline cellulose; hypromellose; macrogol 6000; colloidal anhydrous silica; maize starch; purified talc; brilliant blue fcf aluminium lake - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.